Destra Multi-Alternative Fund Announces Changes To Portfolio Holdings Disclosure Practices

11/10/23 9:04:01 AM ET

Trusts Except Educational Religious and Charitable

Finance

Get the next $DMA alert in real time by email

Effective immediately, the updated Policy provides for the disclosure of the Fund's complete portfolio holdings on the Fund's publicly available website at the end of each month, with a minimum lag time of ten calendar days (the actual posting date may vary if the 10th day is a holiday or weekend, in which case the holdings would be posted on the following business day). Previously, the Fund released its top 10 holdings on a monthly basis and full portfolio holdings on a quarterly basis, with as much as a 60-day lag.

Get the next $DMA alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$DMA

Date	Price Target	Rating	Analyst

More analyst ratings

$DMA
Press Releases

Fastest customizable press release news feed in the world

Destra Multi Alternative Fund Announces the Approval of an Amended and Restated Declaration of Trust
Destra Multi-Alternative Fund (the "Fund" or DMA") announced today that the Fund's Board of Trustees approved an Amended and Restated Declaration of Trust with the addition of a Forum Selection Clause as well as the filing of an 8-K. For more information regarding the Fund, Destra Capital Advisors, and the Amended and Restated Declaration of Trust, visit the Fund webpage below: http://www.destracapital.com/strategies/closed-end-funds/destra-multi-alternative-fund About Destra Multi Alternative Fund: Destra Multi-Alternative Fund (NYSE:DMA) is a core alternative solution that seeks to achieve long-term performance non-correlated to the broad stock and bond markets. Destra Capital A
11/17/23 5:00:00 PM ET
$DMA
Trusts Except Educational Religious and Charitable
Finance
Destra Multi-Alternative Fund Announces Changes to Portfolio Holdings Disclosure Practices
The Destra Multi-Alternative Fund (the "Fund" or "DMA") is pleased to announce that the Fund's Board of Trustees has approved a change to the Fund's holdings disclosure policy (the "Policy") and the frequency of the disclosure will move from quarterly to monthly. Effective immediately, the updated Policy provides for the disclosure of the Fund's complete portfolio holdings on the Fund's publicly available website at the end of each month, with a minimum lag time of ten calendar days (the actual posting date may vary if the 10th day is a holiday or weekend, in which case the holdings would be posted on the following business day). Previously, the Fund released its top 10 holdings on a mont
11/10/23 9:00:00 AM ET
$DMA
Trusts Except Educational Religious and Charitable
Finance
Destra Multi-Alternative Fund Announces Changes to its Structure
Destra Multi-Alternative Fund (DMA) (the "Fund") announced today that the Fund's Board of Trustees (the "Board") has approved a change in the structure of the Fund and effective immediately, the Fund's term will change from perpetual to one that expires pursuant to its Amended and Restated Agreement and Declaration of Trust ("Declaration of Trust"). The Declaration of Trust provides that the Fund, unless certain targets are met, will dissolve at the close of business on March 31, 2027 (concurrent with the end of its 2026-27 fiscal year). The Fund's term may be extended for additional three-year terms beyond March 31, 2027, if certain performance or trading targets are met. If such targe
10/6/23 9:00:00 AM ET
$DMA
Trusts Except Educational Religious and Charitable
Finance

$DMA
Market Insights

Live Market Insights

Destra Multi-Alternative Fund Announces Changes To Portfolio Holdings Disclosure Practices
Effective immediately, the updated Policy provides for the disclosure of the Fund's complete portfolio holdings on the Fund's publicly available website at the end of each month, with a minimum lag time of ten calendar days (the actual posting date may vary if the 10th day is a holiday or weekend, in which case the holdings would be posted on the following business day). Previously, the Fund released its top 10 holdings on a monthly basis and full portfolio holdings on a quarterly basis, with as much as a 60-day lag.
11/10/23 9:04:01 AM ET
$DMA
Trusts Except Educational Religious and Charitable
Finance
Stocks That Hit 52-Week Lows On Tuesday
On Tuesday, 56 companies set new 52-week lows. Noteworthy Highlights From Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was Apellis Pharmaceuticals (NASDAQ:APLS). 9 Meters Biopharma (NASDAQ:NMTR) was the smallest company by market cap to set a new 52-week low. Humanigen (NASDAQ:HGEN)'s stock came under the most pressure, trading down 73.22% to reach a new 52-week low. NeuBase Therapeutics (NASDAQ:NBSE) saw the biggest bounce back on, as shares traded up 0.0% to rebound after it hit its new 52-week low. On Tuesday, the following stocks set new 52-week lows: Apellis Pharmaceuticals (NASDAQ:APLS) stock drifted down 2.25% on Tuesday morning to hi
7/25/23 12:33:02 PM ET
$ACGN
$ADCT
$AIRG
$ALT
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
Biotechnology: Pharmaceutical Preparations
Radio And Television Broadcasting And Communications Equipment
Stocks That Hit 52-Week Lows On Thursday
During Thursday's session, 40 stocks hit new 52-week lows. 52-Week Low Highlights: The largest company by market cap to set a new 52-week low was Crown Castle (NYSE:CCI). The smallest company by market cap to set a new 52-week low was Ucommune International (NASDAQ:UK). Vir Biotechnology (NASDAQ:VIR)'s stock fell the most, as it traded down 44.38% to reach a new 52-week low. Yunji (NASDAQ:YJ)'s stock rebounded the most, as it traded up 0.0% after dropping to a new 52-week low. Here are all the stocks that set new 52-week lows on Thursday: Crown Castle (NYSE:CCI) shares set a new 52-week low of $103.22. The stock traded down 5.62%. Kenvue (NYSE:KVUE) stock broke to a new 52-we
7/20/23 2:01:19 PM ET
$ACGN
$APLS
$APM
$ASTI
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
Biotechnology: Pharmaceutical Preparations
Semiconductors

Destra Multi-Alternative Fund Announces Changes To Portfolio Holdings Disclosure Practices

Chat with this insight

Recent Analyst Ratings for
$DMA

$DMA
SEC Filings

SEC Form N-PX filed by Destra Multi-Alternative Fund

SEC Form N-CEN filed by Destra Multi-Alternative Fund

SEC Form N-CSR filed by Destra Multi-Alternative Fund

$DMA
Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

Large owner Saba Capital Management, L.P. bought $436,465 worth of shares (52,442 units at $8.32) (SEC Form 4)

Large owner Saba Capital Management, L.P. bought $26,737 worth of shares (3,202 units at $8.35) (SEC Form 4)

Large owner Saba Capital Management, L.P. bought $727,881 worth of shares (86,745 units at $8.39) (SEC Form 4)

$DMA
Large Ownership Changes

This live feed shows all institutional transactions in real time.

Amendment: SEC Form SC 13G/A filed by Destra Multi-Alternative Fund

Amendment: SEC Form SC 13D/A filed by Destra Multi-Alternative Fund

Amendment: SEC Form SC 13D/A filed by Destra Multi-Alternative Fund

$DMA
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Large owner Saba Capital Management, L.P. bought $436,465 worth of shares (52,442 units at $8.32) (SEC Form 4)

Large owner Saba Capital Management, L.P. bought $26,737 worth of shares (3,202 units at $8.35) (SEC Form 4)

Large owner Saba Capital Management, L.P. bought $727,881 worth of shares (86,745 units at $8.39) (SEC Form 4)

$DMA
Press Releases

Fastest customizable press release news feed in the world

Destra Multi Alternative Fund Announces the Approval of an Amended and Restated Declaration of Trust